6.50
-0.17(-2.55%)
Currency In USD
| Previous Close | 6.67 |
| Open | 6.69 |
| Day High | 6.77 |
| Day Low | 6.49 |
| 52-Week High | 16.74 |
| 52-Week Low | 4.87 |
| Volume | 805,443 |
| Average Volume | 1.45M |
| Market Cap | 1B |
| PE | -8.67 |
| EPS | -0.75 |
| Moving Average 50 Days | 6.68 |
| Moving Average 200 Days | 10.06 |
| Change | -0.17 |
If you invested $1000 in Wave Life Sciences Ltd. (WVE) since IPO date, it would be worth $406.25 as of July 01, 2025 at a share price of $6.5. Whereas If you bought $1000 worth of Wave Life Sciences Ltd. (WVE) shares 5 years ago, it would be worth $591.45 as of July 01, 2025 at a share price of $6.5.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Wave Life Sciences Announces Oral Presentation of Preclinical Data Supporting WVE-007’s Mechanism (INHBE) to Reduce Fat, Preserve Muscle, and Induce Healthy Weight Loss at ADA's Annual Scientific Sessions
GlobeNewswire Inc.
Jun 20, 2025 8:01 PM GMT
Presentation to highlight WVE-007 (INHBE GalNAc-siRNA) as a potential novel and unique obesity treatment leading to healthy weight loss and supporting preclinical data demonstrating potent and durable reduction in Activin E resulting in fat loss with
Wave Life Sciences to Present at 2025 Jefferies Global Healthcare Conference
GlobeNewswire Inc.
May 29, 2025 12:30 PM GMT
CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that Paul Bolno, M
Wave Life Sciences Announces Appointment of Dr. Christopher Wright as Chief Medical Officer
GlobeNewswire Inc.
May 28, 2025 12:00 PM GMT
Dr. Wright brings deep experience across a wide breadth of therapeutic areas and modalities and will guide clinical development of Wave’s robust RNA medicines pipelineCAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasda